Currently conducting the RECLAIM clinical trial, a multi-center, double-blind, sham-controlled study in Europe and Australia, with U.S. trials planned next.
Founders
Hubert Martens
Company Description
Salvia BioElectronics develops neuromodulation devices for migraine treatment and management.
Market
Chronic migraine treatment
Location
Eindhoven,
Netherlands
Coinvestors
Innovation Industries, Invest-NL, EIC Fund, Inkef, Panakès Partners, SHS Capital, Dolby Family Ventures, Brabant Development Agency (BOM), Thuja Capital